SEXUAL HEALTH

PT-141 (Bremelanotide)

Synthetic cyclic heptapeptide melanocortin-receptor agonist. Sexual-response pathway research.

Dose
10 mg / vial
Form
Lyophilized powder
Purity
>99% HPLC-verified
Origin
U.S. synthesis
PRICE $ TBD
Synthesized in U.S.A. HPLC-verified PharmaGrade

ABOUT THIS COMPOUND

PT-141 (Bremelanotide) 10 MG.

PT-141 (bremelanotide) is a synthetic cyclic heptapeptide that engages the melanocortin receptors, primarily MC3R and MC4R. It is widely investigated for sexual-response pathway research and is the most-studied melanocortin-receptor agonist in the modern literature.

Each lot is solid-phase synthesized in our U.S. facility, HPLC-verified above 99% purity, and lyophilized under inert atmosphere for stable storage.

SPECIFICATIONS

Molecule. Method. Documentation.

Compound Data

Molecular weight
~1,025 Da
Sequence length
7 amino acids (cyclic heptapeptide)
Receptor targets
MC3R, MC4R (primary)
Form
Lyophilized powder
Purity (HPLC)
>99%
Storage
Long-term at -20°C; sealed, dark, dry

Storage & Handling

Storage temperature
-20°C long-term
Shelf life (sealed)
24 months
Reconstituted shelf life
30 days at 2–8°C
Reconstitution
Bacteriostatic water (research use)
Documentation
Lot-specific COA on request

RESEARCH APPLICATIONS

What researchers study.

All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.

  • Melanocortin-receptor pharmacology
  • Sexual-response pathway research
  • MC3R / MC4R comparative studies

QUALITY ASSURANCE

Every vial, the same standard.

U.S. Made Molecule built on American soil
>99% HPLC-verified purity
Lot-Tested COA available on request
PharmaGrade Pharmaceutical-grade synthesis

A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →

YOU MAY ALSO RESEARCH

Related compounds.

QUESTIONS?

Talk to a human.

Lot questions, COA requests, institutional accounts, reach the team directly.

CONTACT US